“…The involvement of anesthesia as well as laparotomy during a cesarean delivery increases the risk for maternal morbidity, such as bleeding and infections 22,23 . Cesarean delivery has been associated with increased morbidity of the offspring in the long term in previous studies 24–26 . Therefore, reconsideration by the clinicians of the indications for cesarean delivery in short‐stature patients is warranted in order to lessen the rising rate of cesarean delivery.…”
Section: Discussionmentioning
confidence: 99%
“…22,23 Cesarean delivery has been associated with increased morbidity of the offspring in the long term in previous studies. [24][25][26] Therefore, reconsideration by the clinicians of the indications for cesarean delivery in short-stature patients is warranted in order to lessen the rising rate of cesarean delivery. Although short stature may be associated with a smaller pelvic inlet, it can be speculated that the higher rate of cesarean delivery is partially attributed to caregiver bias.…”
ObjectiveScarce data exist regarding obstetric complications of short‐stature patients. This study aimed to investigate obstetric and perinatal outcomes in women with short stature; specifically, to investigate whether short‐stature patients are at an increased risk for cesarean delivery.MethodsA population‐based cohort study was conducted, including all singletons born between the years 1991 and 2021 at a tertiary medical center. Obstetric and perinatal outcomes of short‐stature patients were compared with those of non‐short patients. A generalized estimation equation binary logistic model was constructed to adjust for confounders and maternal recurrence in the cohort.ResultsThe study population included 356 356 parturient; among them, 14 035 (3.9%) were short‐stature patients. Short‐stature patients had significantly higher rates of cesarean delivery (20.7% vs 13.7%, odds ratio = 1.64, 95% confidence interval 1.57–1.71, P < 0.001), induction of labor, pathologic presentations, prolonged second stage of labor, non‐reassuring fetal monitoring, and meconium‐stained amniotic fluid. Newborns of short‐stature patients had a significantly higher risk of being small for gestational age as compared with those of non‐short patients. In the generalized estimation equation models, the association between short stature and risk of cesarean delivery remained significant (adjusted odds ratio = 1.32, 95% confidence interval 1.27–1.38, P < 0.001), as well as the risk of small for gestational age newborns (adjusted odds ratio = 1.51, 95% confidence interval 1.40–1.63, P < 0.001), but not for the other adverse outcomes.ConclusionsMaternal short stature is an independent risk factor for cesarean delivery and is associated with small for gestational age newborns.
“…The involvement of anesthesia as well as laparotomy during a cesarean delivery increases the risk for maternal morbidity, such as bleeding and infections 22,23 . Cesarean delivery has been associated with increased morbidity of the offspring in the long term in previous studies 24–26 . Therefore, reconsideration by the clinicians of the indications for cesarean delivery in short‐stature patients is warranted in order to lessen the rising rate of cesarean delivery.…”
Section: Discussionmentioning
confidence: 99%
“…22,23 Cesarean delivery has been associated with increased morbidity of the offspring in the long term in previous studies. [24][25][26] Therefore, reconsideration by the clinicians of the indications for cesarean delivery in short-stature patients is warranted in order to lessen the rising rate of cesarean delivery. Although short stature may be associated with a smaller pelvic inlet, it can be speculated that the higher rate of cesarean delivery is partially attributed to caregiver bias.…”
ObjectiveScarce data exist regarding obstetric complications of short‐stature patients. This study aimed to investigate obstetric and perinatal outcomes in women with short stature; specifically, to investigate whether short‐stature patients are at an increased risk for cesarean delivery.MethodsA population‐based cohort study was conducted, including all singletons born between the years 1991 and 2021 at a tertiary medical center. Obstetric and perinatal outcomes of short‐stature patients were compared with those of non‐short patients. A generalized estimation equation binary logistic model was constructed to adjust for confounders and maternal recurrence in the cohort.ResultsThe study population included 356 356 parturient; among them, 14 035 (3.9%) were short‐stature patients. Short‐stature patients had significantly higher rates of cesarean delivery (20.7% vs 13.7%, odds ratio = 1.64, 95% confidence interval 1.57–1.71, P < 0.001), induction of labor, pathologic presentations, prolonged second stage of labor, non‐reassuring fetal monitoring, and meconium‐stained amniotic fluid. Newborns of short‐stature patients had a significantly higher risk of being small for gestational age as compared with those of non‐short patients. In the generalized estimation equation models, the association between short stature and risk of cesarean delivery remained significant (adjusted odds ratio = 1.32, 95% confidence interval 1.27–1.38, P < 0.001), as well as the risk of small for gestational age newborns (adjusted odds ratio = 1.51, 95% confidence interval 1.40–1.63, P < 0.001), but not for the other adverse outcomes.ConclusionsMaternal short stature is an independent risk factor for cesarean delivery and is associated with small for gestational age newborns.
Antibiotic, analgesic sedative, and antiseizure medications are among the most commonly used medications in preterm/sick neonates, who are at high risk of nosocomial infections, central nervous system complications, and are exposed to numerous painful/stressful procedures. These severe and potentially life-threatening complications may have serious short- and long-term consequences and should be prevented and/or promptly treated. The reported variability in the medications used in neonates indicates the lack of adequate neonatal studies regarding their effectiveness and safety. Important obstacles contributing to inadequate studies in preterm/sick infants include difficulties in obtaining parental consent, physicians’ unwillingness to recruit preterm infants, the off-label use of many medications in neonates, and other scientific and ethical concerns. This review is an update on the use of antimicrobials (antifungals), analgesics (sedatives), and antiseizure medications in neonates, focusing on current evidence or knowledge gaps regarding their pharmacokinetics, indications, safety, dosage, and evidence-based guidelines for their optimal use in neonates. We also address the effects of early antibiotic use on the intestinal microbiome and its association with long-term immune-related diseases, obesity, and neurodevelopment (ND). Recommendations for empirical treatment and the emergence of pathogen resistance to antimicrobials and antifungals are also presented. Finally, future perspectives on the prevention, modification, or reversal of antibiotic resistance are discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.